European Drug Report 2022: Trends and Developments (EMCDDA)
Bibliography: All Publications
Challenges in Identifying Novel Psychoactive Substances and a Stronger Path Forward
The importance of non-targeted testing to keep pace with a rapidly evolving synthetic opioid market (National Institute of Justice)
European Drug Report 2022: Trends and Developments
The Trends and Developments report presents the EMCDDA’s latest analysis of the drug situation in Europe. Focusing on illicit drug use, related harms and drug supply, the report contains a comprehensive set of national data across these themes and key harm-reduction interventions (EMCDDA)
Drug supply and use bounce back after COVID-19 disruption
The rapid bounce back of drug supply and use following COVID-19 disruption is among the issues highlighted today by the EU drugs agency (EMCDDA) as it launches its European Drug Report 2022: Trends and Developments
EU Drugs Agency: Council adopts negotiating mandate on strengthening the role of the agency
To step up the fight against illegal drugs, the Council today adopted its negotiating mandate on the proposal on the EU Drugs Agency, meant to turn the existing European Monitoring Centre for Drugs and Drug Addiction into a fully fledged agency and strengthen its role
Illicit Drug Toxicity Deaths in BC January 1, 2012 – April 30, 2022
This report summarizes all unintentional illicit drug toxicity deaths in British Columbia (accidental and undetermined) that occurred between January 1, 2012, and April 30, 2022, inclusive. It includes confirmed and suspected illicit toxicity deaths (BC Coroners Service)
New HRB report examines substance use among young people
The data highlights an increase in substance-related hospitalisations among young people and that treatment for cocaine use among young people increased by 171% between 2011 and 2019. It also shows a clear link between mental ill health and substance use, evident across data on anxiety, self-harm and suicide (HRB Ireland)
Concern about drug addiction has declined in U.S., even in areas where fatal overdoses have risen the most
The share of Americans who see drug addiction as a “major problem” in their community has declined in recent years, even as drug overdose deaths in the United States have risen sharpl (Pew Research Center)
The Drug Use in Higher Education in Ireland (DUHEI) Survey 2021
This analysis provides the first significant body of evidence on drug use among students in Ireland and will help policymakers, professionals, and practitioners when considering responses to the challenge of reducing harms arising from drug use in higher education (DUHEI)
Expanding overdose prevention sites in Vancouver, Canada, has beneficial health impacts
Overdose prevention sites are a type of supervised injection service that are less regimented and have fewer barriers than traditional supervised injection services. The researchers in this study investigated the impact of this implementation in Vancouver on health outcomes (Recovery Research Institute)
New explorer tool offers access to over 20 years of ESPAD data
European School Survey Project on Alcohol and Other Drugs (ESPAD) is launching a new data explorer tool, allowing access to over 20 years of ESPAD data on substance use among 15-16-year-old student
Five drug-induced deaths per day among Australians in 2020, report finds
The latest Drug Trends report from UNSW’s National Drug and Alcohol Research Centre shows more than 1800 drug-induced deaths in Australia in 2020 (UNSW)
Take Home Naloxone Programme
Annual report on the supply and use of Take Home Naloxone to reverse an overdose April 2020 – March 2021 (PHA Ireland)
EU Drug Markets: In-depth analysis
In-depth analysis’ is a strategic and action-oriented analysis of the information available on Europe’s illicit drug markets. It takes a broad view of these markets from production and trafficking, to distribution and use. It provides a holistic and systemic perspective, capturing key aspects of the wider security and public health consequences of drug markets, as well as the main factors driving change and new threats (EMCDDA)
Publication of the drug misuse prevention review
The report “Preventing drug use among vulnerable groups of people”, commissioned by the Home Office, has been published by the ACMD
Scottish drug misuse database
Overview of Initial Assessments for Specialist Drug Treatment 2020/21: Final Report
Drug misuse prevention review
Advice on preventing drug misuse among vulnerable groups of people, with a focus on understanding factors that contribute to vulnerability (ACMD)
U.S. Overdose Deaths In 2021 Increased Half as Much as in 2020 – But Are Still Up 15%
Provisional data from CDC’s National Center for Health Statistics indicate there were an estimated 107,622 drug overdose deaths in the United States during 2021, an increase of nearly 15% from the 93,655 deaths estimated in 2020. The 2021 increase was half of what it was a year ago, when overdose deaths rose 30% from 2019 to 2020 (CDC)
Civil society monitoring of harm reduction in Europe 2021 data report
This is the third and last civil society-led C-EHRN Monitoring Report which is produced within the framework of the Operating Grant of the EU Health Programme1 (2018-2021). It is time to stand still and look at what we have achieved so far, what still needs to be done and where we see room for improvement (Correlation – European Harm Reduction Network)
Europe’s changing role in expanding cocaine and methamphetamine markets
In an in-depth look at the cocaine and methamphetamine markets, the agencies point to increased production activities in Europe and how collaboration between criminal groups worldwide is creating new security threats and expanding the market (EMCDDA)
National naloxone programme Scotland: annual Monitoring report 2019/20 and 2020/21 An Official Statistics publication for Scotland
This release by Public Health Scotland presents information on the number of take-home naloxone (THN) kits issued by the National Naloxone Programme in Scotland
Letter from the Minister of State for Crime, Policing and Probation to the Chair of the Advisory Council on the Misuse of Drugs
Recommendations (Home Office)
Public Safety and Cannabis: Taking Stock of Knowledge Since Legalization: A Virtual Cannabis Policy Research Symposium Report
Summarizes six research papers on various public safety aspects of cannabis legalization, which were presented at the Public Safety and Cannabis: Taking Stock of Knowledge Since Legalization symposium in January 2022. This report highlights accumulated data and knowledge of the impacts of the Cannabis Act on public safety (CCSA)
Paying providers for good outcomes may be better in theory than practice
This study evaluated the impact of implementing this type of scheme in England’s substance use disorder treatment system, where providers were paid based on treatment outcomes (Recovery Research Institute)
High societies: International experiences of cannabis liberalisation
Across the world, approaches to cannabis regulation are changing. This report reviews evidence from jurisdictions that have liberalised cannabis, assessing how they have impacted health, crime, and economic outcomes, comparing them against the UK’s prohibition regime (Social Market Foundation)
2022 National Drug Control Strategy
This inaugural Strategy proposes bold, targeted, and consequential actions to bend the curve on overdose deaths in the immediate term and reduce drug use and its damaging consequences over the longer term (White House)
Prisons and drugs: health and social responses
This miniguide is one of a larger set, which together comprise Health and social responses to drug problems: a European guide (EMCDDA)
Coca Growing, Cocaine Production Reach New Heights in Honduras
Coca farms and cocaine production camps are proliferating in Honduras, showing that the illicit crop has taken root in the country after years of low-level experimentation InSight Crime)
Drug checking in Australia: how far do we have to go?
This presentation focused on drug checking or pill testing services, which have existed for over 50 years and now operate in more than 20 countries. Despite this long history, little research assessing feasibility or impact has been published in peer-reviewed journals (NDARC)
Alcohol and other drug treatment services in Australia: early insights
Alcohol and other drug treatment services in Australia: early insights presents key statistics about Australia’s publicly funded alcohol and other drug treatment services and their clients. Early insights is a companion report to the data and analysis presented in Alcohol and other drug treatment services in Australia: annual report (AIHW)
Community Urinalysis and Self-Report Project: Cross-Canada Report on the Use of Drugs from the Unregulated Supply, 2019-2021 Data
Presents substance use trends and describes whether expected substance use matched actual substance contents. Data were collected from harm reduction sites in seven regions across Canada that participated in the Community Urinalysis and Self-Report Project between 2019 and 2021 (CCSA)
Extra funding for drug and alcohol treatment: 2022 to 2023
Information about new funding to local councils to help them improve their drug and alcohol treatment and recovery systems (UK Government)
Statistics from the Northern Ireland Substance Misuse Database: 2020/21
The Department of Health today published “Statistics from the Northern Ireland Substance Misuse Database: 2020/21 (Experimental Statistics)” report and accompanying statistical tables
rends in Cannabis Use Prior to First Admission to Inpatient Psychiatry in Ontario, Canada, Between 2007 and 2017 (Report at a Glance) CannabisMental Health
Highlights the correlation between cannabis use and admission to inpatient psychiatry beds in Ontario between 2007 and 2017. The study shows that prior cannabis use was common among people at first admission to inpatient psychiatry. It suggests that trends in use among vulnerable groups, such as those with mental illness, need to be monitored to evaluate the effect of cannabis-related policies on different cohorts of psychiatric inpatients (Canadian Centre on Substance Use and Addiction)
Needle Exchange Surveillance Initiative (NESI)
Prevalence of blood-borne viruses and injecting risk behaviours among people who inject drugs attending injecting equipment provision services in Scotland, 2008 to 2020 (Public Health Scotland)
Recreational settings and drugs: health and social responses
This miniguide is one of a larger set, which together comprise Health and social responses to drug problems: a European guide (EMCDDA)
Women in the cocaine supply chain
The series Cocaine Insights, developed by UNODC in the framework of the CRIMJUST programme and in cooperation with partners and stakeholders at national, regional and international levels, delivers the latest knowledge and trends on issues related to cocaine markets in an accessible and informative format (UNODC)
Treatment target for people with problematic drug use
A national target will be introduced to ensure more people with problematic opiate drug use are accessing life-saving community treatments (Scottish Government)
Penalties for drug law offences in Europe at a glance
Examine and compare the penalties, or rehabilitative responses, for the core offences of drug use, possession for personal use, and supply-related offences, across countries in Europe (EMCDDA)
Latest wastewater data reveal drug-taking habits in 75 European cities in a record 25 countries
Increases in detections of most drugs studied (EMCDDA)
- « Previous Page
- 1
- 2
- 3
- 4
- 5
- 6
- …
- 49
- Next Page »
